Pokaż cały numer - FPN - Farmaceutyczny PrzeglÄ d Naukowy

Nr 7-8 / 2008dostarcza tylko pojedynczych doniesień o możliwym histologicznym16. Tanaka Y.O.,przejściu od łagodnego mięśniaka do mięśniako-mięsaka gładkiego [31,32]. Nie udowodniono hipotezy, żemaciczne mięśniako-mięsaki wynikają lub są powodowanetransformacją złośliwą łagodnych mięśniaków macicy. 17.muscle tumors of uncertain malignant potential and leiomyosacomasof the uterus: MR findings. J Magn ResonImaging 2004; 20: 998-1007.Cooley H.MChemosensitivity testing of fresh and continuous tumorPiśmiennictwo.cell cultures using lactate dehydrogenase. AnticancerRes 1997; 17: 231-236.1. -Cramer 18. Goto S.F., A., Patel Takeuchi A.: The S., freguency Sugimura of S., uterine et al.: leiomy Usefulness ofomas. Am J Clin Pathol1990; 94: 435-438.Gd-DTPA contrast-enhanced dynamic MRI and serumdiagnosis of leiomyosarcoma from degenerated leiomyoma2. S.M., of the Marshall uterus. In L.M., J Gynecol Baird D.D.: Cancer Epidemiolo 2002; 12: 47-52.-Schwartz gic contributions to understanding the etiology of uterineleiomyomata. Environ Heaalth Perspect 2000; 108(Suppl5): 821-827.19. -Meyer W.R., Med leiomyosarcoma: treatment with a gonadotropin-releasinghormone analoge. Obstet Gynecol 1990; 75: 529-532.3. Schwartz 20. P.E., Kelly M.G.: Malignant transformation -Milman D., Zof myomas: myth or reality. Obstet Gynecol Clin N Am2006; 33: 183-198.ine leiomyosarcoma discovered during treatment with agonadotropin-releasing hormone analogue: a case report4. Harlow and B.L., literature Weiss review. N.S., Lofton Eur J Obstet S.: The Gynecol epidemiology Reprod Biolof sarcomas of the uterus. J Natl Cancer Inst 1986; 76: 1998: 76: 237-240.399-402.21. -Schwartz L.B5. -Gadduci sarcomas: A., Landoni clinical F., Sartori presentation. E., et al.: Am Uterine J Obstet leioGynecolmyosarcoma :analysis of treatment failures and survival. 1993; 168: 180-183.Gynecol Oncol 1996; 62: 25-32.22. -Nordal N.N.,6. -Leibshon nostic S., significance d’Ablaing G., of Mishell stage, tumor D.R., size, et al.: cellular Leio atypiamyosarcoma in a series of hysterectomies performed forpresumed uterine leiomyomas. Am J Obstet Gynecol1990; 162: 968-976.23.and DNA pliody in uterine leiomyosarcoma. Acta Oncol1995; 34: 797-802.-Larson B., So7. -Wysowski tic factors D.: Uterine uterine sarcoma leiomyosarcoma: associated with a clinicopathologictamoxifen use. N Engl J Med 2002; 46: 1832-1833.study of 143 cases. The Radiumhemmet series 1936-8. -Giuntoli 1981. R.L., Acta Metzinger Oncol 1990; D.S., Di 29: Marco 185-191. C.S., et al.: Retrospective review of 208 patients with leiomyosarcomaof the uterus: prognostic indicators, surgical managementand adjuvant therapy. Gynecol Oncol 2003; 89:460-469.24. -Major F.J., Bmyosarcoma in a series of hysterectomies performedfor presumed uterine liomyomas. Am J Obstet Gynecol1990; 162: 968-976.9. Hendrickson 25. M.R., Tavassoli F.A., Kempson R., et al.: Friedrich M.Mesenchyme tumors and related lesions. In: TavassoliF.A., Devilee P., editors. Pathology and genetics oftumors of the breast and female genital organs. Lyon:IARC Press; 2003; pp.223-249.leiomyomata with subsequent pregnancy. Zentralbl Gynekol1998; 70: 348-350.26. Van Dinh T.uterus. Am J Obstet Gynecol. 1982; 144: 817-823.10. -Nordal 27. R.R., Kristensen G.B., Kaern J., et al.: The pro -Davis A.M.:gnostic significance of stage, tumor size, cellular atypiaand DNA ploidy in uterine leiomyosarcoma. Acta Oncol1995; 34: 797-802.28.sults in a series of 1150 cases. Am J Obstet Gynecol1952; 63: 592-604.Spies J.B., S11. Bell S.W., after Kempson uterine artery R.L., embolization Hendricson M.R.: for leiomyomas. Problematic Obstetuterine smooth muscle neoplasm: a clinicopatholigic studyof 213 cases. Am J Surg Pathol 1994; 74: 196-201. 29. -Dinh T.A., OGynecol 2002; 100: 873-880.12. Parker ment W.H., of Fu uterine Y.S., leiomyosarcoma: Berek J.S.: Uterine results sarcoma for a in 10-yearpatients operated on for presumed leiomyoma and rapidlygrowing leiomyoma. Obstet Gynecol 1994; 82:414-418.30.experience (1990-1999) at the Massachusetts GeneralHospital. Gynecol Oncol 2004; 92: 648-652.-Mayerhofer K13. Lefebvre myosarcoma G., Vilos G., of the Allaire uterus: C., a et clinicopathologic al.: The management multicenterof uterine leiomyomas. J Obstet Gynecol Can 2003; 25: study of 71 cases. Gynecol Oncol 1999; 74: 196-201.396-418.31. Clement P.B14. -Kido A., PB, Togashi Young K., RH, Koyama editors, T., Tumors et al.: and Diffusely tumor-like enlar lesionsged uterus: evaluation with MR imaging. Radiographics2003; 23: 1423-1439.of the uterine corpus and cervix. New York: ChurchillLivingstone, 1993; pp. 265-328.15. Szklaruk 32. J., Tamm E.P., Choi H., et al.: MR imaging of -Rotmensch Jcommon and uncommon large pelvic masses. Radiographics2003; 23: 403-424.tion of uterine leiomyomata. Int J Gynecol Obstet 1993;42: 47-59.42 FarmaceutycznyPrzegląd Naukowycopyright © 2008 Grupa dr. A. R. KwiecińskiegoISSN 1425-5073